Here are four things to know:
1. The first quarter marked the company’s largest revenue quarter to date.
2. Sales of FLXfit 3D Expanding TLIF Cage largely spurred the growth.
3. The first quarter saw a significant increase in new surgeon users of the FLXfit.
4. The company expects to continue its strong growth throughout 2017.
EOI Vice President of U.S. Sales Dale Binke said, “Our record-breaking quarter was highlighted by strong clinical acceptance which accelerated our growth in both MIS and open surgical approaches.”
More articles on devices:
How single-use instruments facilitate jump from inpatient to outpatient total knee arthroplasty
Johnson & Johnson, US Defense Dept. reach $260M deal on orthopedic devices — 4 takeaways
Orthofix launches JuniOrtho to serve pediatric patients — 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
